Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Cell Line Validation in Biomanufacturing
Confirming Identity, Purity, Sterility, and Functionality of Cell Lines Helps Keep Patients Safe
For full access to this article login to GEN Select now.
CerCell’s Building-Block Bioreactors
Danish Company Focuses on Configurable-Batch, Single-Use Bioreactors and Fermenters
- Denmark-based CerCell specializes in single-use bioprocess products. According to company founder and CEO Per Strobbe, the company’s expertise lies in its ability to offer fully customizable, scalable single-use bioreactors and single-use fermenters. When asked about why he thinks his company is so well positioned in the single-use market, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.